Image via Financial Post
Last updated
Takeda: Leadership Change
Julie Kim officially appointed as Takeda's Representative Director, President and Chief Executive Officer, completing an 18-month CEO transition
Source: Financial Post
The leadership read
Leadership transitions often precede broader healthcare bench-strengthening over the next two quarters.
Market context: Backdrop: a 105.9 (Hot) Talent Market Index (down 2.3 on the month) with Americas activity rising (+2.4pts).
Takeda: 5 signals in the last 90 days; 0.2% of MitchelLake's Americas signal flow; 5 tracked across 68 days.
Also at Takeda →
More signals across Healthcare
Leadership Change · Americas
Alkermes →Blair Jackson has joined Alkermes as incoming CEO with an explicit strategy to compete in the orexin drug market against larger competitors like Eli Lilly and Takeda. Jackson signals the next 12 months are critical for the company's competitive positioning.
Leadership Change · Americas
HCA Healthcare →Dr. Michael Cuffe, chief clinical officer of HCA Healthcare since 2022, is departing at the end of August 2026 after 4 years in the role.
Strategic Hiring · Americas
United States Air Force →Air Force stood up first rapidly deployable counter-drone units (~20 enlisted Airmen per unit) and announced new base defense job specialty code career path to address evolving drone threats.
Restructuring · Americas
Kaiser Permanente →Kaiser Permanente has implemented AI-driven performance monitoring systems for nursing staff, measuring call duration and tone/empathy, triggering labor disputes and strikes. The system incentivizes shorter calls and script adherence, creating tension between efficiency metrics and patient care quality.
Ma Activity · Americas
Vertex Pharmaceuticals →Vertex Pharmaceuticals announced acquisition of Crinetics Pharmaceuticals for $10 billion, gaining approved drug Palsonify (acromegaly) and pipeline candidates including congenital adrenal hyperplasia therapy.
Ma Activity · Americas
Apellis Pharmaceuticals →Apellis Pharmaceuticals was acquired by Biogen for $5.6 billion, indicating major integration and potential restructuring
Intelligence powered by Autonodal ↗